Polyphosphate Reverses the Toxicity of the Quasi-Enzyme Bleomycin on Alveolar Endothelial Lung Cells In Vitro †

SIMPLE SUMMARY: Bleomycin (BLM) is a medication introduced used to treat various types of cancer, including testicular cancer, ovarian cancer, and Hodgkin’s disease. Its most serious side effect is pulmonary fibrosis and impaired lung function. Using A549 human lung cells it is shown that, in parall...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Werner E. G., Neufurth, Meik, Wang, Shunfeng, Schröder, Heinz C., Wang, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916961/
https://www.ncbi.nlm.nih.gov/pubmed/33670189
http://dx.doi.org/10.3390/cancers13040750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916961/
https://www.ncbi.nlm.nih.gov/pubmed/33670189
http://dx.doi.org/10.3390/cancers13040750

Ejemplares similares